David Meltzer

7.9k total citations · 1 hit paper
98 papers, 4.2k citations indexed

About

David Meltzer is a scholar working on General Health Professions, Economics and Econometrics and Pharmacology. According to data from OpenAlex, David Meltzer has authored 98 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in General Health Professions, 47 papers in Economics and Econometrics and 10 papers in Pharmacology. Recurrent topics in David Meltzer's work include Healthcare Policy and Management (31 papers), Health Systems, Economic Evaluations, Quality of Life (28 papers) and Healthcare cost, quality, practices (17 papers). David Meltzer is often cited by papers focused on Healthcare Policy and Management (31 papers), Health Systems, Economic Evaluations, Quality of Life (28 papers) and Healthcare cost, quality, practices (17 papers). David Meltzer collaborates with scholars based in United States, Netherlands and Canada. David Meltzer's co-authors include Jeanette W. Chung, Saima Chaudhry, Lei Jin, Wendy Levinson, R. Scott Braithwaite, Douglas Leslie, Joseph T. King, Mark S. Roberts, Anirban Basu and Diane S. Lauderdale and has published in prestigious journals such as JAMA, Circulation and Annals of Internal Medicine.

In The Last Decade

David Meltzer

96 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

What Does the Value of Modern Medicine Say About the $50,000 per Quality-Adjusted Life-Year Decision Rule?

2008 471 citations R. Scott Braithwaite, David Meltzer et al. Medical Care profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Meltzer United States	32	1.7k	1.4k	553	514	462	98	4.2k
John Peabody United States	33	1.9k 1.1×	1.2k 0.9×	314 0.6×	914 1.8×	464 1.0×	162	5.4k
Cameron Mustard Canada	43	2.9k 1.7×	842 0.6×	355 0.6×	640 1.2×	621 1.3×	178	6.1k
Jay Bhattacharya United States	39	1.3k 0.8×	1.2k 0.8×	283 0.5×	862 1.7×	942 2.0×	169	5.5k
Anita K. Wagner United States	33	1.3k 0.7×	1.9k 1.4×	351 0.6×	744 1.4×	749 1.6×	122	6.1k
José F. Figueroa United States	30	1.8k 1.1×	1.3k 0.9×	349 0.6×	692 1.3×	321 0.7×	156	4.1k
Soeren Mattke United States	39	3.6k 2.1×	1.7k 1.2×	731 1.3×	750 1.5×	654 1.4×	192	7.5k
Amal N. Trivedi United States	34	2.6k 1.5×	2.1k 1.5×	340 0.6×	689 1.3×	493 1.1×	214	4.9k
L. Gary Hart United States	34	2.2k 1.2×	1.3k 1.0×	321 0.6×	1.5k 2.9×	404 0.9×	73	5.6k
John Hsu United States	39	2.0k 1.1×	1.8k 1.3×	236 0.4×	495 1.0×	455 1.0×	171	4.9k
Sally C. Stearns United States	43	2.6k 1.5×	1.5k 1.1×	281 0.5×	963 1.9×	368 0.8×	171	6.0k

Countries citing papers authored by David Meltzer

Since Specialization

Citations

This map shows the geographic impact of David Meltzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Meltzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Meltzer more than expected).

Fields of papers citing papers by David Meltzer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Meltzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Meltzer. The network helps show where David Meltzer may publish in the future.

Co-authorship network of co-authors of David Meltzer

This figure shows the co-authorship network connecting the top 25 collaborators of David Meltzer. A scholar is included among the top collaborators of David Meltzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Meltzer. David Meltzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

O’Leary, Kevin J., Edith A. Nutescu, Tai C. Chen, et al.. (2025). Results of the ACCOuNT Trial: A Multi‐Institutional Prospective Pharmacogenomics Implementation Trial for African American Inpatients. Clinical Pharmacology & Therapeutics. 119(1). 109–119. 1 indexed citations

O’Leary, Kevin J., Edith A. Nutescu, Tai C. Chen, et al.. (2025). Care Team Attributes Predict Likelihood of Utilizing Pharmacogenomic Information During Inpatient Prescribing. Clinical and Translational Science. 18(4). e70193–e70193. 1 indexed citations

Prochaska, Micah T., et al.. (2024). The Design and Early Results of a Structured Longitudinal Training Program for Undergraduate Students to Increase Diversity in Aging-Research. The International Journal of Aging and Human Development. 99(4). 460–475. 1 indexed citations

Meltzer, David, et al.. (2024). Missed opportunities: Lack of a diagnostic workup of anaemia results in a high prevalence of unidentified anaemia. Vox Sanguinis. 120(2). 163–169.

Prochaska, Micah T., David Meltzer, & Peter Angelos. (2023). When Guideline-Concordant Standardized Care Results in Healthcare Disparities. The Journal of Clinical Ethics. 34(3). 225–232. 1 indexed citations

Meltzer, David, et al.. (2021). Primary care physician involvement during hospitalisation: a qualitative analysis of perspectives from frequently hospitalised patients. BMJ Open. 11(12). e053784–e053784. 5 indexed citations

Farnan, Jeanne M., Shannon K. Martin, Laura Ruth Venable, et al.. (2020). A Peer-Led Social Media Intervention to Improve Interest in Research Careers Among Urban Youth: Mixed Methods Study. JMIR Medical Education. 6(1). e16392–e16392. 2 indexed citations

Apfelbaum, Jeffrey L., Sajid Shahul, Magdalena Anițescu, et al.. (2019). The ImPreSS Trial: Implementation of Point‐of‐Care Pharmacogenomic Decision Support in Perioperative Care. Clinical Pharmacology & Therapeutics. 106(6). 1179–1183. 13 indexed citations

Hui, Zhang, et al.. (2019). Simulation-based optimization to improve hospital patient assignment to physicians and clinical units. Health Care Management Science. 23(1). 117–141. 24 indexed citations

10.

Baal, Pieter van, Alec Morton, David Meltzer, & Werner Brouwer. (2018). Future unrelated medical costs need to be considered in cost effectiveness analysis. The European Journal of Health Economics. 20(1). 1–5. 22 indexed citations

11.

Siddique, Juned, Gregory W. Ruhnke, Andrea Flores, et al.. (2015). Applying Classification Trees to Hospital Administrative Data to Identify Patients with Lower Gastrointestinal Bleeding. PLoS ONE. 10(9). e0138987–e0138987. 11 indexed citations

12.

Kho, Abel, John Cashy, Bala Hota, et al.. (2012). The Chicago Health Atlas: A Public Resource to Visualize Health Conditions and Resources in Chicago.. AMIA. 3 indexed citations

13.

Hoomans, Ties, et al.. (2012). CO3 Minimizing the Costs of Analyzing the Value of Health Research. Value in Health. 15(4). A2–A2.

14.

Stein, Brian, Glen T. Schumock, Todd A. Lee, et al.. (2011). The Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Diagnosis Codes for Identifying Patients Hospitalized for COPD Exacerbations. CHEST Journal. 141(1). 87–93. 114 indexed citations

15.

Zhang, James, et al.. (2009). Physical and Mental Health in Adults Hospitalized with Sickle Cell Disease: Impact on Resource Use. Journal of the National Medical Association. 101(2). 139–144. 6 indexed citations

16.

Schneider, John A., Qi Zhang, Andrew D. Auerbach, et al.. (2008). Do Hospitalists or Physicians with Greater Inpatient HIV Experience Improve HIV Care in the Era of Highly Active Antiretroviral Therapy? Results from a Multicenter Trial of Academic Hospitalists. Clinical Infectious Diseases. 46(7). 1085–1092. 13 indexed citations

17.

Braithwaite, R. Scott, David Meltzer, Joseph T. King, Douglas Leslie, & Mark S. Roberts. (2008). What Does the Value of Modern Medicine Say About the $50,000 per Quality-Adjusted Life-Year Decision Rule?. Medical Care. 46(4). 349–356. 471 indexed citations breakdown →

18.

Manns, Braden, David Meltzer, Ken Taub, & Cam Donaldson. (2003). Illustrating the impact of including future costs in economic evaluations: an application to end‐stage renal disease care. Health Economics. 12(11). 949–958. 53 indexed citations

19.

Meltzer, David, Brian L. Egleston, & Ibrahim Abdalla. (2001). Patterns of prostate cancer treatment by clinical stage and age. American Journal of Public Health. 91(1). 126–128. 45 indexed citations

20.

Meltzer, David. (2001). Theoretical Foundations of Medical Cost-Effectiveness Analysis -- Implications for the Measurement of Benefits and Costs of Medical Interventions. NBER Chapters. 97–118. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact